MarcusA.NeubauerMD

Oncology • Seattle, WA

Assistant Professor, Internal Medicine, University Kansas School of Medicine

Join to view full profile

Dr. Neubauer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Neubauer's full profile

Already have an account?

Office
825 Eastlake Ave E
Seattle, WA 98109
Phone+1 855-557-0555

Fax+1 206-606-1025
Is this information wrong?

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1991 - 1993
University of Kansas School of MedicineResidency, Internal Medicine, 1988 - 1991
University of Kansas School of MedicineClass of 1988

Certifications & Licensure

WA State Medical License 1991 - 2023
MO State Medical License 1993 - 2014
KS State Medical License Active through 2013

Awards, Honors, & Recognition

Top MD Consumers Checkbook
Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

10 citations
Three-Year Results of a Medicare Advantage Cancer Management Program.
J. Russell Hoverman, Marcus A. Neubauer, Melissa Jameson, Jad Hayes, Kathryn Eagye, Mitra Abdullahpour, Wendy J Haydon, Maria Sipala, Amy Supraner, Michael A. Kolodzie...> ;Journal of Oncology Practice. 2018 Mar 16
6 citations
Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer.
Cynthia Osborne, Jagathi D. Challagalla, Charles F. Eisenbeis, Frankie A. Holmes, Marcus A. Neubauer, Nicholas Koutrelakos, Carlos A. Taboada, Sasha Vukelja, Sharon Wi...> ;Clinical Breast Cancer. 2017 Jul 10
10 citations
Improving incidence of code status documentation through process and discipline.
Marcus A. Neubauer, Cynthia Taniguchi, J. Russell Hoverman> ;Journal of Oncology Practice. 2015 Mar 1
202 citations
Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer
Joyce O'Shaughnessy, Lee S. Schwartzberg, Michael A. Danso, Kathy D. Miller, Hope S. Rugo, Marcus Neubauer, Nicholas J. Robert, Beth A. Hellerstedt, Mansoor N. Saleh, ...> ;Journal of Clinical Oncology. 2014 Oct 27
40 citations
Opening the black box: the impact of an oncology management program consisting of level I pathways and an outbound nurse call system
J. Russell Hoverman, Ira Klein, Debra W. Harrison, Jad Hayes, Jody S. Garey, Robyn K. Harrell, Maria Sipala, Scott Houldin, Melissa Jameson, Mitra Abdullahpour, Jessic...> ;Journal of Oncology Practice. 2014 Jan 1
59 citations
Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomise...
Edward S. Kim, Marcus A. Neubauer, Allen Lee Cohn, Lee S. Schwartzberg, Lawrence Garbo, John Robert Caton, Francisco Robert, Craig W. Reynolds, Terry L. Katz, Sreeni C...> ;The Lancet. Oncology. 2013 Dec 1
53 citations
Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation w...
Shadia I. Jalal, H. D. Riggs, Anton Melnyk, Donald A. Richards, A. K. Agarwala, Marcus A. Neubauer, Rafat Ansari, Ramaswamy Govindan, D. Bruetman, William B. Fisher, T...> ;Annals of Oncology. 2012 Jul 1
139 citations
Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy
Samir E. Witta, Robert M. Jotte, Katrik Konduri, Marcus A. Neubauer, Alexander I. Spira, Robert L. Ruxer, Marileila Varella-Garcia, Paul A. Bunn, Fred R. Hirsch> ;Journal of Clinical Oncology. 2012 Apr 16
45 citations
Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors
Matthew D. Galsky, Daniel D. Von Hoff, Marcus A. Neubauer, Thomas Anderson, Mark D. Fleming, Yasir Nagarwala, Janine M. Mahoney, Dawn Midwinter, Linda Vocila, Tal Zaks> ;Investigational New Drugs. 2012 Apr 1
23 citations
A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer.
Alexander I. Spira, Nicholas Iannotti, Michael Savin, Marcus A. Neubauer, Nashat Y. Gabrail, Ronald H. Yanagihara, Edith A. Zang, Patricia E. Cole, Dale E. Shuster, As...> ;Clinical Lung Cancer. 2012 Jan 1
Utilization of pegfilgrastim in adjuvant chemotherapy regimens for breast cancer in the community.
Patt DA, Espirito JL, Turnwald B, Hoverman JR, Neubauer MA, Busby LT, Brooks BD, Kolodziej MA, Anderson RW, Beveridge RA> ;J. Clin. Oncol.. 2011-09-20
37 citations
Benchmarks for value in cancer care: an analysis of a large commercial population.
Michael Kolodziej, J. Russell Hoverman, Jody S. Garey, Janet L. Espirito, Sheetal Sheth, Aimee Ginsburg, Marcus A. Neubauer, Debra A. Patt, Barry Don Brooks, Charles W...> ;Journal of Oncology Practice. 2011 Sep 1
31 citations
An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancer.
Allen Lee Cohn, Grace C. Shumaker, Pankaj Khandelwal, David Smith, Marcus A. Neubauer, Nilesh D. Mehta, Donald A. Richards, David L. Watkins, Kathy Zhang, M. Yassine> ;Clinical Colorectal Cancer. 2011 Sep 1
7 citations
Creating a Process to Standardize Regimen Order Sets Within an Electronic Health Record
Leslie T. Busby, Sheetal Sheth, Jody S. Garey, Aimee Ginsburg, Thomas Flynn, Michael A. Willen, Scott Kruger, Marcus A. Neubauer, Michael A. Kolodziej, David C. Chang,...> ;Journal of Oncology Practice. 2011 Jul 1
Utilization and relative value of breast cancer adjuvant chemotherapy regimens in the community.
Patt DA, Espirito JL, Turnwald B, Hoverman JR, Neubauer MA, Cartwright TH, Brooks BD, Busby LT, Sitarik MA, Kolodziej MA, Ginsburg AL, Sheth S, Garey JS, Clayton M, Ne...> ;J. Clin. Oncol.. 2011-05-20
Bevacizumab therapy in advanced non-small cell lung cancer (NSCLC): Outcomes from a community oncology network.
Neubauer MA, Garey JS, Nelson GC, Patt DA, Cartwright TH, Hoverman JR, Busby LT, Brooks BD, Sitarik MA, Kolodziej MA, Anderson RW, Beveridge RA> ;J. Clin. Oncol.. 2011-05-20
Understanding male breast cancer in the community setting.
Ginsburg AL, Patt DA, Flinn J, Espirito JL, Neubauer MA, Cartwright TH, Hoverman JR, Busby LT, Brooks BD, Kolodziej MA, Sitarik MA, Anderson RW, Beveridge RA> ;J. Clin. Oncol.. 2011-05-20
33 citations
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases.
J Russell Hoverman, Thomas H Cartwright, Debra A Patt, Janet L Espirito, Matthew P Clayton, Jody S Garey, Terrance J Kopp, Michael Kolodziej, Marcus A Neubauer, Kathry...> ;Journal of Oncology Practice. 2011 May 1
57 citations
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databases.
J Russell Hoverman, Thomas H Cartwright, Debra A Patt, Janet L Espirito, Matthew P Clayton, Jody S Garey, Terrance J Kopp, Michael Kolodziej, Marcus A Neubauer, Kathry...> ;The American Journal of Managed Care. 2011 May 1
20 citations
A Phase III Randomized Trial of Gemcitabine–Oxaliplatin versus Carboplatin–Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer
Charles Weissman, Craig H. Reynolds, Marcus A. Neubauer, Sharon Pritchard, Svetlana Kobina, Lina Asmar> ;Journal of Thoracic Oncology. 2011 Feb 1
9 citations
A Phase II Trial of Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer Who Have Received Prior Taxane Therapy
John Pippen, Anthony D. Elias, Marcus A. Neubauer, Christopher Stokoe, LaTrice G. Vaughn, Yanping Wang, Mauro Orlando, Oluwatoyin O. Shonukan, Joseph Muscato, Joyce O'...> ;Clinical Breast Cancer. 2010 Apr 1
73 citations
Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer
J. Randolph Hecht, Edith P. Mitchell, Marcus A. Neubauer, Howard A. Burris, Paul D. Swanson, Timothy Lopez, Glenn Buchanan, Maureen Reiner, Jennifer Gansert, Jordan Be...> ;Clinical Cancer Research. 2010 Apr 1
127 citations
Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting
Marcus A. Neubauer, J. Russell Hoverman, Michael A. Kolodziej, Lonny Reisman, Stephen K. Gruschkus, Susan Hoang, Albert A. Alva, Marilyn McArthur, Michael Forsyth, Tod...> ;Journal of Oncology Practice. 2010 Jan 1
Commentary: Do Guidelines Influence Physician Practice Behavior? The Experience With Erythropoiesis-Stimulating Agents
Marcus A. Neubauer, Roy A. Beveridge, Michael Kolodziej> ;Journal of Oncology Practice. 2009 Sep 1
Results from panitumumab (pmab) regimen evaluation in colorectal cancer to estimate primary response to treatment (PRECEPT): Second-line treatment with pmab and FOLFIR...
Cohn AL, Smith DA, Neubauer MA, Houston G, Khandelwal P, Wiggans RG, Zhang K, Yassine M> ;J. Clin. Oncol.. 2009-05-20
Join now to see all

Press Mentions

Cancer Care in the COVID-19 World: Adjusting to a New RealityJuly 31st, 2020
Clinical Pathways: Reducing Costs and Improving Quality Across a NetworkFebruary 19th, 2020
Fifteen Practices in the US Oncology Network Earn High-Quality Performance Ratings in the Oncology Care Model, Saving Medicare $35 MillionOctober 8th, 2019
Join now to see all